Imricor Medical Systems, Inc.

ASX:IMR.AX

1.7 (AUD) • At close June 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q2
Omzet 0.5520.4080.4170.1990.2780.5380.330.3660.4250.2780.5850.0550.3160.6860.2830.2830.3520.352
Kosten van de omzet 0.9360.9480.790.9420.9481.3951.4441.1480.7330.3670.377000000.1070.107
Brutowinst -0.384-0.54-0.373-0.742-0.67-0.857-1.114-0.782-0.308-0.090.2080.0550.3160.6860.2830.2830.2440.244
Brutowinstmarge -0.696-1.325-0.896-3.731-2.408-1.593-3.376-2.135-0.725-0.3230.355111110.6950.695
Onderzoek- en ontwikkelingskosten 4.3823.79943.923.4834.4635.0014.6743.1132.4331.8331.7681.7791.7472.4452.4451.9651.965
Algemene en administratieve kosten 2.3652.5552.2812.8072.0822.9012.9372.8822.1932.1361.5821.0530.8030.7870000
Verkoop- en marketingkosten 1.1051.1671.081.6521.3161.4891.4541.4140.9810.7030.3240.2490.330.3730000
Verkoop-, algemene en administratieve kosten 3.473.7233.3614.4593.3984.3894.3924.2963.1742.8391.9061.3021.1341.161.0441.0441.0041.004
Overige kosten 0-0-0000000000000000
Bedrijfskosten 7.8517.5217.368.4776.8918.8698.6839.0616.2265.5518.0374.5032.8152.8493.4893.4892.9692.969
Bedrijfsresultaat -8.235-8.061-7.734-9.121-7.551-9.709-10.507-9.752-6.595-5.362-3.531-3.016-2.597-2.221-3.272-3.272-2.725-2.725
Bedrijfsresultaat ratio -14.928-19.77-18.566-45.834-27.156-18.048-31.835-26.63-15.53-19.319-6.035-55.298-8.217-3.235-11.569-11.569-7.742-7.742
Totaal overige inkomsten en kosten netto -14.5991.203-5.672-0.099-0.03-0.0670.737-0.21-0.054-0.436-4.713-2.034-0.35-0.281-0.084-0.084-0.023-0.023
Inkomen voor belasting -22.835-6.858-13.406-9.22-7.581-9.776-9.77-9.962-6.649-5.798-8.244-5.05-2.946-2.502-3.355-3.355-2.747-2.747
Inkomen voor belasting ratio -41.392-16.819-32.183-46.329-27.263-18.172-29.603-27.203-15.658-20.89-14.088-92.59-9.324-3.645-11.865-11.865-7.806-7.806
Belastingkosten 0000000000000000-0-0
Nettowinst -22.835-6.858-13.406-9.22-7.581-9.776-9.77-9.962-6.649-5.798-8.244-5.05-2.946-2.502-3.355-3.355-2.747-2.747
Nettowinstmarge -41.392-16.819-32.183-46.329-27.263-18.172-29.603-27.203-15.658-20.89-14.088-92.59-9.324-3.645-11.865-11.865-7.806-7.806
WPA (Winst Per Aandeel) -0.089-0.036-0.083-0.061-0.051-0.068-0.072-0.079-0.057-0.056-0.107-0.115-0.07-0.06-0.035-0.035-0.029-0.029
Verwaterde WPA -0.089-0.036-0.083-0.061-0.051-0.068-0.072-0.079-0.057-0.056-0.107-0.115-0.07-0.06-0.035-0.035-0.029-0.029
EBITDA -7.857-7.692-7.381-8.767-7.178-9.369-10.15-9.42-6.295-5.134-3.338-2.952-2.555-2.184-3.207-3.207-2.652-2.652
EBITDA ratio -14.242-18.864-17.719-44.052-25.815-17.417-30.753-25.724-14.824-18.497-5.704-54.129-8.087-3.182-11.342-11.342-7.535-7.535